LQDA - NASDAQ

Liquidia Corporation

LQDA·NASDAQ

$55.69

+1.5%

HealthcareBiotechnology

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.95B

EPS-0.8000

P/E Ratio-69.61

Earnings Date08/11/2026

lqda

Total Stockholders' Equity

Last Annual Value

44.75M

3-Year CAGR

-21%

5-Year CAGR

-9%

10-Year CAGR

16%

Adjust for Inflation

Liquidia Corporation Competitors Analysis of Total Stockholders' Equity

LQDA · NASDAQ

Company	Total Stockholders' Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
Liquidia Corporation NASDAQ:LQDA	44.75M	-1.8%	-7.3%	N/A
Cogent Biosciences, Inc. NASDAQ:COGT	636.37M	35.1%	24.3%	28.4%
Structure Therapeutics Inc. NASDAQ:GPCR	1.52B	49.6%	N/A	N/A
Denali Therapeutics Inc. NASDAQ:DNLI	1.01B	-0.6%	1.0%	14.8%
89bio, Inc. NASDAQ:ETNB	400.79M	-9.3%	26.0%	N/A
ImmunityBio, Inc. NASDAQ:IBRX	-499.57M	N/A	N/A	N/A
Arcus Biosciences, Inc. NYSE:RCUS	631.00M	11.0%	-5.6%	20.3%
Ocular Therapeutix, Inc. NASDAQ:OCUL	654.31M	92.9%	49.4%	28.8%
Agios Pharmaceuticals, Inc. NASDAQ:AGIO	1.19B	13.7%	-1.6%	12.8%

Liquidia Corporation Fair Value Envelope

LQDA · NASDAQ

Our analysis suggests that LQDA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $55.69, this represents a potential HIDDEN relative to our calculated worth for Liquidia Corporation.

HIDDEN

Intrinsic Value

Current Price: $55.69

Related Guides

Blog Categories

Continue your LQDA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.